Trillium Therapeutics stock

Pfizer to Acquire Trillium Therapeutics Inc.

GlobeNewswire - 24 Aug 2021
Proposed acquisition strengthens Pfizer's category leadership in Oncology with addition of next-generation, investigational immuno-therapeutics for...

• More

Trillium Therapeutics' stock nearly triples after buyout deal with Pfizer valued at $2.26 billion

MarketWatch - 23 Aug 2021
Trillium Therapeutics' stock nearly triples after buyout deal with Pfizer valued at $2.26 billion  ...

• More

Pfizer to buy Canadian ‘blockbuster’ cancer drug developer Trillium Therapeutics in $2.26-billion deal

The Globe and Mail - 23 Aug 2021
Pfizer to buy Canadian ‘blockbuster’ cancer drug developer Trillium Therapeutics in $2.26-billion deal  ...

• More

Pfizer to Acquire Trillium Therapeutics Inc.

Business Wire - 23 Aug 2021
Pfizer to Acquire Trillium Therapeutics Inc.  ...

• More

UPDATE: Pfizer and Trillium: How a $25M investment led to a $2.3B buyout

Fierce Biotech - 14 Sep 2021
UPDATE: Pfizer and Trillium: How a $25M investment led to a $2.3B buyout  ...

• More

Cancer Drug Bet Pays Off for Biotech CEO With 3,600% Stock Surge

Bloomberg - 30 Sep 2020
Cancer Drug Bet Pays Off for Biotech CEO With 3,600% Stock Surge  ...

• More

Trillium (TRIL) to be Acquired by Pfizer for $2.3 Billion

Yahoo Finance - 24 Aug 2021
Trillium (TRIL) to be Acquired by Pfizer for $2.3 Billion  ...

• More

Jan Skvarka, former Trillium CEO, on Driving a Turnaround

Timmerman Report - 30 Mar 2023
Jan Skvarka, former Trillium CEO, on Driving a Turnaround  ...

• More

Pfizer to acquire Trillium in $2.3bn deal

BioProcess Insider - 03 Mar 2024
Pfizer to acquire Trillium in $2.3bn deal  ...

• More

Trillium follows positive data and $25M equity investment with $130M offering

BioWorld Online - 11 Sep 2020
Trillium follows positive data and $25M equity investment with $130M offering  ...

• More

Seagen obtains rights to HER2 ADC disitamab vedotin in a deal worth up to $2.4 billion

PPF Group - 04 Sep 2022
Seagen obtains rights to HER2 ADC disitamab vedotin in a deal worth up to $2.4 billion  ...

• More

The top 10 biopharma M&A deals in 2021

FiercePharma - 18 Jan 2022
The top 10 biopharma M&A deals in 2021  ...

• More

Pfizer in advanced talks to buy Global Blood Therapeutics for $5 billion, Wall Street Journal reports

Reuters - 05 Aug 2022
Pfizer in advanced talks to buy Global Blood Therapeutics for $5 billion, Wall Street Journal reports  ...

• More

Viridian Appoints Scott Myers as President and Chief Executive Officer

GlobeNewswire - 06 Feb 2023
Viridian Appoints Scott Myers as President and Chief Executive Officer  ...

• More

Pfizer swallows CD47 biotech Trillium in $2.3B takeover

Fierce Biotech - 23 Aug 2021
Pfizer swallows CD47 biotech Trillium in $2.3B takeover  ...

• More

Edesa stock soars after Toronto biotech shares data showing COVID-19 antibody saves lives

The Globe and Mail - 20 Sep 2021
Edesa stock soars after Toronto biotech shares data showing COVID-19 antibody saves lives  ...

• More

Wall Street gains, Nasdaq notches record closing high on full vaccine approval

Reuters - 23 Aug 2021
Wall Street gains, Nasdaq notches record closing high on full vaccine approval  ...

• More

Bellus shareholders approve US$2-billion takeover by GSK; deal set to close this month

The Globe and Mail - 16 Jun 2023
Bellus shareholders approve US$2-billion takeover by GSK; deal set to close this month  ...

• More

Pfizer undeterred in CD47 plans as competitors face pitfalls

Fierce Biotech - 28 Jul 2022
Pfizer undeterred in CD47 plans as competitors face pitfalls  ...

• More

Ozempic maker Novo Nordisk bulks up on weight loss drugs, buying Montreal’s Inversago for $1-billion

The Globe and Mail - 10 Aug 2023
Ozempic maker Novo Nordisk bulks up on weight loss drugs, buying Montreal’s Inversago for $1-billion  ...

• More